Skip to content
Screener

Insulet PODD Gross Carrying Amount

Gross Carrying Amount at other companies

Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$1.24B+131%
Medtronic logo
MedtronicMDT
AptarGroup logo
AptarGroupATR
TOI
TOITOI

Other financials

Income statement

See full
Revenue$801.7M+23.5%
Gross profit$562.6M+24.4%
Operating income$129.7M+7.1%
Net income$95.0M+322%
EPS (diluted)$1.37+328%

Balance sheet

See full
Cash & equivalents$534.9M-52.3%
Total debt$974.7M-47.6%
Total equity$1.4B-2.8%
Total assets$3.2B-8.8%

Cash flow

See full
Operating cash flow$88.4M-55.0%
CapEx$32.5M+74.7%
Free cash flow$55.9M-68.6%

Valuation

See full
Market cap$9.79B-54.4%
Enterprise value$10.23B-53.9%
P/E26.1×-64.8×
P/S3.2×-5.9×

Profitability

See full
Gross margin71.1%+0.3pp
Operating margin16.9%-0.4pp
Net margin12.3%+2.3pp
FCF margin9.6%-7.5pp

Returns & leverage

See full
Return on equity26%+6.8pp
Debt / equity0.7×-0.6×
Current ratio2.5×+0.2×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The source filing: Insulet’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001145197-26-000169
(in millions)June 30, 2026 / Gross Carrying AmountJune 30, 2026 / Accumulated AmortizationJune 30, 2026 / Net Book ValueDecember 31, 2025 / Gross Carrying AmountDecember 31, 2025 / Accumulated AmortizationDecember 31, 2025 / Net Book Value
Customer relationships$43.1$(36.7)$6.4$43.2$(35.8)$7.4
Internal-use software76.2(20.1)56.168.3(14.1)54.2
Developed technology28.3(8.0)20.328.3(6.9)21.4
Patents44.0(11.8)32.244.0(9.9)34.2
Total intangible assets$191.6$(76.5)$115.1$183.8$(66.7)$117.1

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Insulet's gross carrying amount?
Insulet (PODD) reported gross carrying amount of $191.6M in Q2 2026.
How has Insulet's gross carrying amount changed year-over-year?
Insulet's gross carrying amount increased by 17.2% year-over-year, from $163.5M to $191.6M.
What is the long-term trend for Insulet's gross carrying amount?
Over 5 years (2020 to 2025), Insulet's gross carrying amount has grown at a 26.9% compound annual growth rate (CAGR), from $55.8M to $183.8M.
What does gross carrying amount mean?
Gross Carrying Amount

Ask your AI about Insulet's gross carrying amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude